A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...
The study identifies mechanisms by which drug-resistant lung cancer cells alter the tumor microenvironment, leading to cancer recurrence and reduced efficacy of targeted therapies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback